Back to top
more

Cabot (CBT)

(Delayed Data from NYSE)

$77.51 USD

77.51
870,553

-0.58 (-0.74%)

Updated Sep 19, 2025 04:00 PM ET

After-Market: $77.53 +0.02 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (227 out of 245)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Add Univar (UNVR) to Your Portfolio

by Zacks Equity Research

Univar (UNVR) stands to gain from a strong demand for its services, solid overseas operations and meaningful acquisitions. Rewarding shareholders and making growth investments remain priorities.

    Zacks Equity Research

    Monsanto (MON) & Pairwise to Jointly Roll Out Agro Solutions

    by Zacks Equity Research

    Monsanto (MON) and agricultural start-up firm, Pairwise Plants, to jointly roll out breakthrough crop-yield enhancing solutions with gene-editing technology.

      Anindya Barman headshot

      Here's Why You Should Add Cabot (CBT) Stock to Your Portfolio

      by Anindya Barman

      Healthy growth prospects and upbeat outlook make Cabot (CBT) an attractive investment option.

        Zacks Equity Research

        Eastman Chemical (EMN) to Raise Price of Choline Chloride

        by Zacks Equity Research

        Eastman Chemical (EMN) is taking appropriate actions amid an escalated raw material pricing environment.

          Zacks Equity Research

          Zacks.com highlights: ArcBest, Cabot, Avianca Holdings, PetroChina and Finish Line

          by Zacks Equity Research

          Zacks.com highlights: ArcBest, Cabot, Avianca Holdings, PetroChina and Finish Line

            Zacks Equity Research

            Tap 5 Value Stocks Sporting Enticing EV/EBITDA Ratios

            by Zacks Equity Research

            We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.

              Zacks Equity Research

              Here's Why You Should Add Praxair (PX) to Your Portfolio

              by Zacks Equity Research

              Praxair (PX) stands to gain from a solid product portfolio and increasing applications of industrial gases. Returning value to shareholders is a priority.

                Zacks Equity Research

                Mosaic (MOS) Beats Earnings and Revenue Estimates in Q4

                by Zacks Equity Research

                Solid performance across all segments contributed to Mosaic's (MOS) results in Q4.

                  Zacks Equity Research

                  Agnico Eagle (AEM) Tops on Q4 Earnings, Ups Production View

                  by Zacks Equity Research

                  While Agnico Eagle (AEM) has raised its production view for 2018, it sees a year-over-year increase in AISC this year.

                    Zacks Equity Research

                    Air Products to Buy Europe's Leading Carbon Dioxide Business

                    by Zacks Equity Research

                    Air Products' (APD) latest deal will help the company to foray into newer regions of Europe as a liquid carbon dioxide supplier.

                      Zacks Equity Research

                      Celanese (CE) Set to Raise Price of Low Density Polyethylene

                      by Zacks Equity Research

                      Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which are likely to lend support to its margins.

                        Zacks Equity Research

                        Kinross (KGC) Misses Earnings and Revenue Estimates in Q4

                        by Zacks Equity Research

                        Kinross' (KGC) results are adversely impacted by lower gold production in Q4.

                          Zacks Equity Research

                          Cabot (CBT) Earnings & Revenues Surpass Estimates in Q1

                          by Zacks Equity Research

                          Solid segment performances contributed to Cabot's (CBT) results in Q1.

                            Zacks Equity Research

                            Chemical Stock Earnings to Watch on Feb 6: AXTA, CBT & More

                            by Zacks Equity Research

                            Most of the chemical stocks reporting earnings on Feb 6 are unlikely to impress.

                              Zacks Equity Research

                              Why Cabot Corp. (CBT) Might Surprise This Earnings Season

                              by Zacks Equity Research

                              Cabot (CBT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                Zacks Equity Research

                                Is a Beat in the Cards for Cabot Corp (CBT) in Q1 Earnings?

                                by Zacks Equity Research

                                Growth-focused investments are likely to support Cabot Corp's (CBT) earnings in Q1.

                                  Zacks Equity Research

                                  4 Chemical Stocks Well Poised to Trump Earnings Estimates

                                  by Zacks Equity Research

                                  Chemical makers continue to see strong demand from construction and automotive sectors - major chemical end-use markets.

                                    Zacks Equity Research

                                    Cabot Corp (CBT) Q4 Earnings Miss, Revenues Beat Estimates

                                    by Zacks Equity Research

                                    Cabot (CBT) reported a year-over-year decrease in adjusted earnings for fiscal fourth quarter that missed the Zacks Consensus Estimate.

                                      Zacks Equity Research

                                      Mosaic's (MOS) Earnings and Revenues Top Estimates in Q3

                                      by Zacks Equity Research

                                      Strong operational performance and better price realization boosted Mosaic's (MOS) bottom line in Q3.

                                        Zacks Equity Research

                                        Will Higher Shipments Drive WestRock (WRK) Q4 Earnings?

                                        by Zacks Equity Research

                                        WestRock's (WRK) fourth-quarter fiscal 2017 results will benefit from seasonally higher volumes, sales price increases, favorable mix and productivity. However, higher input costs will dent results.

                                          Zacks Equity Research

                                          Can CVR Partners (UAN) Spring a Surprise in Q3 Earnings?

                                          by Zacks Equity Research

                                          Weak nitrogen prices are likely to dent CVR Partners' (UAN) earnings in Q3.

                                            Zacks Equity Research

                                            Goldcorp's (GG) Q3 Earnings In Line, Revenues Miss Estimates

                                            by Zacks Equity Research

                                            Strong operating performance at Cerro Negro and Penasquito drives Goldcorp's (GG) third-quarter 2017 earnings.

                                              Zacks Equity Research

                                              Agnico-Eagle (AEM) Q3 Earnings Top, Ups Production Outlook

                                              by Zacks Equity Research

                                              Record gold production and strong cash flow drives Agnico-Eagle's (AEM) Q3 performance.

                                                Zacks Equity Research

                                                Should You Buy Cabot Corporation (CBT) Ahead of Earnings?

                                                by Zacks Equity Research

                                                Cabot Corporation (CBT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                                  Zacks Equity Research

                                                  Is a Beat in the Cards for Cabot Corp (CBT) in Q4 Earnings?

                                                  by Zacks Equity Research

                                                  Cabot Corp's (CBT) fourth-quarter fiscal 2017 earnings are expected to gain from higher volumes across performance chemicals' end markets and lower fixed costs in purification solutions.